News
SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve™, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability
SURPRISE, Ariz., May 8, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the...
SenesTech Announces Exclusive Distribution Agreement and Initial Order for Evolve™ Soft Bait in Indonesia
SURPRISE, Ariz., May 7, 2025 -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces its entry into an exclusive distribution agreement with Asa Jaya Mandiri LTD (AJM) for the...
SenesTech to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, May 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report first quarter 2025 financial results for the period ended March 31, 2025,...
SenesTech’s Evolve™ Deployed in Chicago Neighborhoods
PHOENIX, April 17, 2025 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today confirmed the expanding deployment of EvolveTM Rat Birth Control in the Wicker Park Bucktown Special Service Area of...
SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025
PHOENIX, March 31, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2025...
SenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDA
Company announces new operating optimization initiatives to reduce expenses by approximately $2 million to accelerate path to profitability PHOENIX, March 12, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control...
SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds
PHOENIX, March 10, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding...
SenesTech to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 12, 2025
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, March 6, 2025 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2024, ended December 31, 2024, after the...
SenesTech Expands its Rapidly Growing Global Footprint and Clears Major Regulatory Hurdle, Paving the Way for Use in Australia and New Zealand
SenesTech and Distribution Partner to Bring Evolve™ to New Zealand's Predator Free 2050 Initiative PHOENIX, Feb. 25, 2025 -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce a...
SenesTech Expands into Warehousing and Distribution Sector with Multi-Pallet Initial Shipment of Evolve Rodent Birth Control™
PHOENIX, Ariz., Feb. 18, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech"), a pioneer in humane rodent pest control solutions, is pleased to announce the shipment of a substantial order of its Evolve™ Rodent Birth Control product to one of the largest...